Patents Assigned to Bio-Id Diagnostic Inc.
  • Patent number: 11028442
    Abstract: The invention refers to a method of detecting one or more deoxyribose nucleotide (e.g. DNA) template(s) in a heterogenous sample by generation of template specific surrogate nucleotide sequences. This invention is applied to but not restricted in detecting genetic variations including cancer markers and pathogens.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: June 8, 2021
    Assignee: Bio-ID Diagnostic Inc.
    Inventor: Thuraiayah Vinayagamoorthy
  • Patent number: 10351899
    Abstract: Provided are methods for detecting and analyzing polynucleotides in a biological sample or sample derived therefrom for example, using a synthetic template polynucleotide. In some aspects, a target polynucleotide in the sample hybridizes to the template polynucleotide and is extended by a polymerase, generating an extended target polynucleotide. In some examples, the extended target polynucleotide is amplified, for example, by polymerase chain reaction, and sequences of the target polynucleotide determined, for example, by priming in the region of the extended target polynucleotide generated by extension and sequencing towards the region having identity to the target polynucleotide. In some aspects, the target polynucleotide is thereby detected in the sample and its sequence identified.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: July 16, 2019
    Assignee: Bio-ID Diagnostics Inc.
    Inventor: Thuraiayah Vinayagamoorthy
  • Patent number: 10036053
    Abstract: A method of determining whether or not a nucleic acid having an expected sequence or one or more variants of the expected sequence are present in a sample containing nucleic acids after replication, transcription or editing (or other transformation) of a substrate nucleic acid. The method involves deciding an expected sequence likely to be formed in the sample upon the replication, transcription or editing of the substrate nucleic acid, and possible variants of the expected sequence, providing primer pairs for a polymerase chain reaction, reverse transcriptase polymerase chain reaction or ligase chain reaction, carrying out the polymerase chain reaction or reverse transcriptase polymerase chain reaction in one or more steps to form amplicons, and analyzing the amplicons to determining whether or not a nucleic acid having the expected sequence and/or variants are present in the sample.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: July 31, 2018
    Assignee: Bio-ID Diagnostics Inc.
    Inventor: Thuraiayah Vinayagamoorthy
  • Publication number: 20170166954
    Abstract: Provided are methods for detecting and analyzing polynucleotides in a biological sample or sample derived therefrom for example, using a synthetic template polynucleotide. In some aspects, a target polynucleotide in the sample hybridizes to the template polynucleotide and is extended by a polymerase, generating an extended target polynucleotide. In some examples, the extended target polynucleotide is amplified, for example, by polymerase chain reaction, and sequences of the target polynucleotide determined, for example, by priming in the region of the extended target polynucleotide generated by extension and sequencing towards the region having identity to the target polynucleotide. In some aspects, the target polynucleotide is thereby detected in the sample and its sequence identified.
    Type: Application
    Filed: September 25, 2014
    Publication date: June 15, 2017
    Applicant: Bio-ID Diagnostic Inc.
    Inventor: Thuraiayah VINAYAGAMOORTHY
  • Patent number: 9150906
    Abstract: A method of determining whether or not a nucleic acid having an expected sequence or one or more variants of the expected sequence are present in a sample containing nucleic acids after replication, transcription or editing (or other transformation) of a substrate nucleic acid. The method involves deciding an expected sequence likely to be formed in the sample upon the replication, transcription or editing of the substrate nucleic acid, and possible variants of the expected sequence, providing primer pairs for a polymerase chain reaction, reverse transcriptase polymerase chain reaction or ligase chain reaction, carrying out the polymerase chain reaction or reverse transcriptase polymerase chain reaction in one or more steps to form amplicons, and analyzing the amplicons to determining whether or not a nucleic acid having the expected sequence and/or variants are present in the sample.
    Type: Grant
    Filed: June 28, 2006
    Date of Patent: October 6, 2015
    Assignee: BIO-ID DIAGNOSTIC INC.
    Inventor: Thuraiayah Vinayagamoorthy
  • Patent number: 8785130
    Abstract: Disclosed is the use of artificially-generated nucleic acid coded markers to monitor nucleic acid amplification and sequencing reactions designed to detect or analyze biological samples. The markers generally include, along with a unique sequence preferably including coded section designed to represent one or more factors of interest, primer annealing sequences so that the marker may be amplified and sequenced in the same process and using the same amplification and sequencing primers as for the sample target. The invention also relates to the marker itself, and other uses, such as identifying the origin of various materials or products.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: July 22, 2014
    Assignee: Bio-Id Diagnostic Inc.
    Inventor: Thuraiayah Vinayagamoorthy
  • Patent number: 7727745
    Abstract: A method of producing single-stranded DNA. In one form, the method involves providing a uracil-containing oligonucleotide template molecule having a sequence that is complementary to a part of a target single-stranded DNA molecule of length greater than the template molecule; providing one or more parts of the target molecule including a base sequence complementary to a part of the template molecule; annealing the part(s) of the target molecule to the template molecule and forming the complete target molecule by ligating together at least two adjacent parts of the target molecule while annealed to the template molecule, and/or extending at least one part of the target molecule to form a sequence complementary to a remainder of the template molecule by nucleotide polymerization, and then separating the template molecule from the target molecule.
    Type: Grant
    Filed: August 14, 2006
    Date of Patent: June 1, 2010
    Assignee: Bio-ID Diagnostic Inc.
    Inventor: Thuraiayah Vinayagamoorthy
  • Patent number: 6197510
    Abstract: The invention provides a method of sequencing a nucleic acid in a reaction mixture comprising first and second nucleic acid target sequences. The target sequences may be present on the same or different nucleic acid molecules. First and second labelled sequencing primers are provided that are hybridizable, respectively, to the first and second nucleic acid target sequences. The second sequencing primer being at least as long as the total length of the first sequencing primer plus the length of the first target sequence. Each of the sequencing primer extension products beginning with the second sequencing primer will be longer than the primer extension products in the pool beginning with the first sequencing primer. Once the sequencing reactions have been completed, the lengths of the primer extension products in the pool may be detected by known methods, such as by gel electrophoresis.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: March 6, 2001
    Assignee: Bio-Id Diagnostic Inc.
    Inventor: Thuraiayah Vinayagamoorthy